Evaluation of the Liver for Metastatic Disease

Erik K. Paulson

doi:10.1055/s-2001-15498

Seminars in Liver Disease, Table of Contents

Semin Liver Dis 2001; 21(2): 225-236
DOI: 10.1055/s-2001-15498

Evaluation of the Liver for Metastatic Disease

Erik K. Paulson

Department of Radiology, Duke University Medical Center, Durham, North Carolina

Abstract

ABSTRACT

Metastatic disease of the liver accounts for the vast majority of detected liver masses. In patients with suspected metastatic disease, cross-sectional imaging with ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI) is critical. In the group of patients undergoing evaluation for hepatic surgery, it is even more important to optimize techniques to detect and localize metastatic disease. With improvements in technology and contrast agents, there are several approaches to imaging the liver for metastatic disease. The approach will vary by institution. This article will attempt to provide an overview of the general issues relevant to imaging metastatic disease, highlight the advantages and disadvantages of one modality compared to another, and illustrate the appearance of metastases using US, CT, and MRI.

KEYWORD

Computed tomography - liver - magnetic resonance imaging - metastasis of the liver - metastases detection

Full Text

References

REFERENCES

1 Baker M E, Paulson E K. Hepatic metastatic disease. In: Meyers MA, ed. Neoplasms of the Digestive Tract: Imaging, Staging, and Management Philadelphia: Lippincott-Raven 1998: 361-395
2 Black W C, Welch H G. Screening for disease. AJR . 1997; 168 3-11
3 Abrams H L, Spiro R, Goldstein N. Metastases in carcinoma. Cancer . 1950; 3 74-85
4 Parker S L, Tong T, Bolden S. Cancer statistics, 1997. CA Cancer J Clin . 1997; 47 5-13
5 Porte R J, Clavien P-A. Epidemiology and natural history of liver tumors. In: Clavien P-A, ed. Malignant Liver Tumors: Current and Emerging Therapies Malden, MA: Blackwell Science 1999: 27-36
6 Wagner J S, Atson M A, Van Heerden A J. The natural history of hepatic metastases from colorectal cancer: a comparison with resective treatment. Ann Surg . 1984; 199 502-508
7 Helton W S. The diagnostic and therapeutic approaches to the patient with liver malignancy. In: Clavien P-A, ed. Malignant Liver Tumors: Current and Emerging Therapies Malden, MA: Blackwell Science 1999: 62-85
8 Fink S, Chaudhuri K. Physiological considerations in imaging liver metastases from colorectal carcinoma. Am J Physiol Imag . 1991; 6 150-160
9 McCuskey R S. The hepatic microvascular system. In: Arias IM, Boyer JL, Fausto JL, et al, eds. The Liver: Biology and Pathobiology, 4th ed New York: Lippincott-Raven 1994: 1089-1106
10 Baker M E, Pelley R. Hepatic metastases: basic principles and implication for radiologists. Radiology . 1995; 197 329-337
11 Morgan-Parkes J H. Metastases: mechanisms, pathways and cascades. AJR . 1995; 164 1075-1082
12 Lin G, Lunderquist A, Hagerstran I. Postmortem examination of the blood supply and vascular pattern of small liver metastases in man. Surgery . 1984; 96 517-526
13 Lin G, Hagerstrand I, Lunderquist A. Portal blood supply of liver metastases. AJR . 1984; 143 53-55
14 Kan Z, Ivancev K, Lunderquist A. In vivo microscopy of hepatic tumors in animal models: a dynamic investigation of blood supply to hepatic metastases. Radiology . 1993; 187 621-626
15 Haugeberg G, Strohmeyer T, Lierse W. The vascularization of liver metastases. J Cancer Res Clin Oncol . 1988; 114 415-419
16 Mahfouz A E, Hamm B, Mathieu D. Imaging of metastases to the liver. Eur Radiol . 1996; 6 607-614
17 Rubin J M, Bude R O, Carson P L. Power Doppler US: a potentially useful alternative to mean frequency-based color Doppler ultrasound. Radiology . 1994; 190 853-856
18 Bude R O, Rubin J M. Power Doppler sonography. Radiology . 1996; 200 21-23
19 Tanaka S, Kitamura T, Fujita M. Color Doppler imaging of liver tumors. AJR . 1990; 154 509-514
20 Ralls P W, Johnson M B, Lee K P. Color Doppler sonography in hepatocellular carcinoma. Am J Physiol Imaging . 1991; 6 57-61
21 Nino-Murcia M, Ralls P W, Jeffrey Jr B R. Color Doppler characterization of focal hepatic lesions. AJR . 1992; 159 1195-1197
22 Taylor K JW, Ramon I, Morse S S. Focal liver masses: differential diagnosis with pulsed Doppler US. Radiology . 1987; 164 643-647
23 Ohnishi K, Nomura F. Ultrasonic Doppler studies of hepatocellular carcinoma and comparison with other hepatic focal lesions. Gastroenterology . 1989; 97 1489-1497
24 Sheafor D H, Killius J S, Paulson E K. Hepatic parenchymal enhancement during triple phase helical CT: can it be used to predict which patients with breast cancer will develop hepatic metastases?. Radiology . 2000; 214 875-880
25 Leen E, Angerson W J, Wotherspoon H. Detection of colorectal liver metastases: comparison of laparotomy, CT, US, Doppler perfusion index and evaluation of postoperative follow-up results. Radiology . 1995; 195 113-116
26 Leen E, Goldberg J A, Robertson J. Detection of hepatic metastases using duplex/color Doppler sonography. Ann Surg . 1991; 214 599-604
27 Platt J F, Francis I R, Ellis J H, Reige K A. Liver metastases: early detection based on abnormal contrast material enhancement at dual-phase helical CT. Radiology . 1997; 205 49-53
28 Miles K A, Dugdale P E, Leggett D A. CT measurements of hepatic perfusion in colorectal cancer: correlation with outcome at one year. Radiology (Abstr). 1998; 209 485
29 Remer E M, Gore R M. Liver: normal anatomy in examination techniques. In: Gore RM, Levine MS, ed. Textbook of Gastrointestinal Radiology, 2nd ed Philadelphia: Lippincott-Raven; 2000: 1416-1441
30 Goldberg B B, Liu J-B, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol . 1994; 20 319-333
31 Tanaka S, Kitamra T, Yoshioka F. Effectiveness of galactose-based intravenous contrast medium on color Doppler sonography of deeply located hepatocellular carcinoma. Ultrasound Med Biol . 1993; 21 157-160
32 Tano S, Ueno N, Tomiyama T. Possibility of differentiating small hyperechoic liver tumours using contrast-enhanced color Doppler ultrasonography: a preliminary study. Clin Radiol . 1997; 52 41-45
33 Leen E, McArdle C S. Ultrasound contrast agents in liver imaging. Clin Radiol . 1996; 51(S1) 35-39
34 Forsberg F, Liu J-B, Merton D A. Parenchymal enhancement and tumor visualization using a new sonographic contrast agent. J Ultrasound Med . 1995; 14 949-957
35 Mattrey R F, Wrigley R, Steinbach G C. Gas emulsions as ultrasound contrast agents: preliminary results in rabbits and dogs. Inv Radiol . 1994; 29(S2) 139-141
36 Blomley M J, Albrecht T, Cosgrove D O. Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with US contrast agent SHU508A: early experience. Radiology . 1999; 210 409-416
37 Parker K J, Baggs R B, Lerner R M. Ultrasound contrast for hepatic tumors using IDE particles. Invest Radiol . 1990; 25 1135-1139
38 Rawool N M, Forsberg F, Liu J. US contrast enhancement in conventional and harmonic imaging modes. Radiology . 1996; 201(P) 514
39 Heiken J P, Brink J A, Vannier W. Spiral (helical) CT. Radiology . 1993; 189 647-656
40 Heiken J P, Brink J A, Sagel S S. Helical CT: abdominal applications. Radiology . 1994; 14 919-924
41 Oliver III H J, Baron R L. Helical biphasic contrast-enhanced CT of the liver: technique, indications, interpretation, and pitfalls. Radiology . 1996; 201 1-14
42 Hollett M D, Jeffrey Jr B R, Nino-Murcia M. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (≤1.5 cm) malignant hepatic neoplasms. AJR . 1995; 164 879-884
43 Paulson E K, McDermott V G, Keogan M T. Carcinoid metastases to the liver: the role of triple phase helical CT. Radiology . 1998; 206 143-150
44 Sheafor D H, Frederick M G, Paulson E K. Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phases helical CT for the detection of liver metastases in women with breast carcinoma. AJR . 1999; 172 961-968
45 Matsui O, Takashima T, Kadoya M. Liver metastases from colorectal cancers: detection with CT during arterial portography. Radiology . 1987; 165 65-69
46 Nelson R C, Chezmar J L, Sugarbaker P H, Bernardino M E. Hepatic tumors: comparison of CT during arterial portography, delayed CT, and MR imaging for preoperative evaluation. Radiology . 1989; 172 27-34
47 Heiken J P, Weyman P J, Lee J K. Detection of focal hepatic masses; prospective evaluation with CT, delayed CT, CT during arterial portography, and MR imaging. Radiology . 1989; 171 47-51
48 Soyer P, Laissy J-P, Sibert A. Focal hepatic masses: comparison of detection during arterial portography with MR imaging and CT. Radiology . 1994; 190 737-740
49 Paulson E K, Baker M E, Payne S S. Detection of focal hepatic masses: STIR MR versus CT during arterial portography. JCAT . 1994; 18 581-587
50 Bluemke D A, Paulson E K, Choti M A. Detection of hepatic lesions in candidates for surgery: comparison of ferumoxides enhanced MR imaging and dual phase helical CT. AJR . 2000; 175 1653-1658
51 Paulson E K, Baker M E, Hilleren D J. CT arterial portography: causes of technical failure and variable liver enhancement. AJR . 1992; 159 745-749
52 Paulson E K, Baker M E, Spritzer C E. Focal fatty infiltration: a cause of nontumorous defects in the left hepatic lobe during CT arterial portography. JCAT . 1993; 17 590-595
53 Gao L, Heath D G, Kuszyk B S, Fishman E K. Automatic liver segmentation technique for three-dimensional visualization of CT data. Radiology . 1996; 201 359-364
54 Johnson P T, Heath D G, Kuszyk B S, Fishman E K. CT angiography with volume rendering: advantages and applications in splanchnic vascular imaging. Radiology . 1996; 200 564-568
55 Rubin G D, Dake M D, Napel S A. Three-dimensional spiral CT angiography of the abdomen: initial clinical experience. Radiology . 1993; 186 147-152
56 Foley W D, Mallisee T A, Wilson C R. Multiphase hepatic CT with a multislice scanner. Radiology . 1999; 213(P) 124
57 Wong K, Paulson E K, Nelson R C. Breath-held 3D CT imaging of the liver using multidetector row helical CT. Radiology . 2001; 219 75-79
58 Valls C, Andia E, Sanchez A. Hepatic metastases from colorectal cancer: preoperative detection and assessment of resectability with helical CT. Radiology . 2001; 218 55-61
59 Semelka R C, Mitchell D G, Reinhold C. The liver and biliary system. In: Higgins CB, Ricak H, Helms CA, eds. Magnetic Resonance Imaging of the Body, 3rd ed. Philadelphia:: Lippincott-Raven 1997: 591-639
60 Semelka R C, Helmberger T KG. State of the art colon contrast agents for MR imaging of the liver. Radiology . 2001; 218 27-39
61 Heiken J P. Liver. In: Lee JKT, Sagel SS, Stanley RJ, Heiken JP, eds. Computed Body Tomography with MRI Correlation Philadelphia: Lippincott-Raven 1998: 701-779
62 Harned R K, Chezmar J L, Nelson R C. Imaging of patients with potentially resectable hepatic neoplasms. AJR . 1992; 159 1191-1194
63 Small W C, Mehard W B, Langmo L S. Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography. AJR . 1993; 161 319-322
64 Heyneman L E, Nelson R C. Modality for imaging liver tumors. In: Clavien P-A, ed. Malignant Liver Tumors: Current and Emerging Therapies Malden, MA: Blackwell Science 1999: 46-62
65 Gazelle G S, Goldberg S N, Solbiati L, Livraghi T. State of the art colon tumor ablation with radiofrequency energy. Radiology . 2000; 217 633-647
66 Lee F T. Preoperative imaging of hepatic cancer: what the surgeon needs to know. Presented at the Abdominal Radiology Postgraduate Course; Kaui, Hawaii; March 2000
67 Ralls P W, Jeffrey R B. The liver. In: Jeffrey RB, Ralls PW, eds. Sonography of the Abdomen New York: Raven 1995: 71-179
68 Dodd III D G, Esola C C, Memel D S. Sonography: the undiscovered jewel of interventional radiology. Radio Graphics . 1996; 16 1271-1288